Carmell Depreciation And Amortization vs Other Operating Expenses Analysis
| CTCX Stock | 0.28 0.02 7.69% |
Carmell Therapeutics financial indicator trend analysis is way more than just evaluating Carmell Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Carmell Therapeutics is a good investment. Please check the relationship between Carmell Therapeutics Depreciation And Amortization and its Other Operating Expenses accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Carmell Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Carmell Stock please use our How to Invest in Carmell Therapeutics guide.
Depreciation And Amortization vs Other Operating Expenses
Depreciation And Amortization vs Other Operating Expenses Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Carmell Therapeutics Depreciation And Amortization account and Other Operating Expenses. At this time, the significance of the direction appears to have pay attention.
The correlation between Carmell Therapeutics' Depreciation And Amortization and Other Operating Expenses is -0.72. Overlapping area represents the amount of variation of Depreciation And Amortization that can explain the historical movement of Other Operating Expenses in the same time period over historical financial statements of Carmell Therapeutics, assuming nothing else is changed. The correlation between historical values of Carmell Therapeutics' Depreciation And Amortization and Other Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Depreciation And Amortization of Carmell Therapeutics are associated (or correlated) with its Other Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Operating Expenses has no effect on the direction of Depreciation And Amortization i.e., Carmell Therapeutics' Depreciation And Amortization and Other Operating Expenses go up and down completely randomly.
Correlation Coefficient | -0.72 |
| Relationship Direction | Negative |
| Relationship Strength | Weak |
Depreciation And Amortization
The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Carmell Therapeutics. It is also known as Carmell Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most indicators from Carmell Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Carmell Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Carmell Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Carmell Stock please use our How to Invest in Carmell Therapeutics guide.Tax Provision is expected to grow at the current pace this year. Selling General Administrative is likely to drop to about 2.5 M in 2024
| 2010 | 2022 | 2023 | 2024 (projected) | Interest Expense | 2.5M | 3.7M | 889.3K | 844.9K | Depreciation And Amortization | 242.1K | 242.6K | 124.8K | 162.5K |
Carmell Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Carmell Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Carmell Stock Analysis
When running Carmell Therapeutics' price analysis, check to measure Carmell Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Carmell Therapeutics is operating at the current time. Most of Carmell Therapeutics' value examination focuses on studying past and present price action to predict the probability of Carmell Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Carmell Therapeutics' price. Additionally, you may evaluate how the addition of Carmell Therapeutics to your portfolios can decrease your overall portfolio volatility.